BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1980959)

  • 1. Molecular analysis of human bladder cancer.
    Olumi AF; Skinner EC; Tsai YC; Jones PA
    Semin Urol; 1990 Nov; 8(4):270-7. PubMed ID: 1980959
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors.
    Sidransky D; Messing E
    Urol Clin North Am; 1992 Nov; 19(4):629-39. PubMed ID: 1441021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urothelial cancers. Cytogenetic and molecular biology principles].
    Strohmeyer T
    Urologe A; 1994 Mar; 33(2):122-7. PubMed ID: 7909968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel bladder tumour suppressor genes.
    Knowles MA
    Electrophoresis; 1999 Feb; 20(2):269-79. PubMed ID: 10197433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical appraisal of tumor markers in bladder cancer.
    Fradet Y; Cordon-Cardo C
    Semin Urol; 1993 Aug; 11(3):145-53. PubMed ID: 8105526
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations associated with bladder cancer.
    Cordon-Cardo C; Dalbagni G; Sarkis AS; Reuter VE
    Important Adv Oncol; 1994; ():71-83. PubMed ID: 7911446
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prognostic factors and markers used in urothelial carcinoma of the bladder].
    Billerey C; Vieillefond A
    Ann Pathol; 1999; 19(5 Suppl):S107-9. PubMed ID: 10599469
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of chromosome 9 in human bladder cancer.
    Miyao N; Tsai YC; Lerner SP; Olumi AF; Spruck CH; Gonzalez-Zulueta M; Nichols PW; Skinner DG; Jones PA
    Cancer Res; 1993 Sep; 53(17):4066-70. PubMed ID: 8358736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways of development and progression in bladder cancer: new correlations between clinical observations and molecular mechanisms.
    Jones PA; Droller MJ
    Semin Urol; 1993 Nov; 11(4):177-92. PubMed ID: 8290824
    [No Abstract]   [Full Text] [Related]  

  • 12. Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer.
    Ito M; Habuchi T; Watanabe J; Higashi S; Nishiyama H; Wang L; Tsuchiya N; Kamoto T; Ogawa O
    Urology; 2004 Jul; 64(1):74-8. PubMed ID: 15245939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of prognosis in superficial bladder cancer.
    Fradet Y
    Semin Urol; 1992 Feb; 10(1):28-38. PubMed ID: 1565901
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder.
    Knowles MA; Habuchi T; Kennedy W; Cuthbert-Heavens D
    Cancer Res; 2003 Nov; 63(22):7652-6. PubMed ID: 14633685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization.
    Voorter C; Joos S; Bringuier PP; Vallinga M; Poddighe P; Schalken J; du Manoir S; Ramaekers F; Lichter P; Hopman A
    Am J Pathol; 1995 Jun; 146(6):1341-54. PubMed ID: 7778674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Vanni R; Scarpa RM
    Cancer Res; 1986 Sep; 46(9):4873. PubMed ID: 3731134
    [No Abstract]   [Full Text] [Related]  

  • 17. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].
    Shou J; Wang M; Ma J
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression in superficial bladder cancer in a tumor-model-system (RBT).
    Knopf HJ; von Moorselaar RJ; Debruyne FM; Schalken JA
    Investig Urol (Berl); 1994; 5():76-9. PubMed ID: 7719325
    [No Abstract]   [Full Text] [Related]  

  • 19. Bladder cancer.
    Ozen H
    Curr Opin Oncol; 1996 May; 8(3):259-63. PubMed ID: 8794154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA flow cytometric analysis and numerical chromosome 9 aberrations detected by interphase cytogenetics in superficial bladder TCC.
    Eleuteri P; Grollino MG; Pomponi D; Calugi G; Rocchi M; De Vita R
    Eur J Histochem; 1997; 41 Suppl 2():161-2. PubMed ID: 9859830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.